Approval and Commercialization of Novel Foods in the European Union: Requirements, Evaluation, and Procedure
The Regulatory Framework for Novel Foods in the EU
Food innovation is progressing rapidly, driving the emergence of new ingredients, production processes, and nutritional sources. To ensure consumer safety and market transparency, the approval of Novel Foods in the EU is governed by a strict and detailed legal framework.
The Regulation (EU) 2015/2283, together with the scientific evaluation of the European Food Safety Authority (EFSA), defines the criteria, procedures, and requirements necessary to authorize the commercialization of new foods within the European market.
What Is Considered a “Novel Food” Under EU Law
According to Article 3 of Regulation (EU) 2015/2283, a “Novel Food” is any food that was not consumed to a significant degree within the European Union before 15 May 1997, and that belongs to at least one of the categories specified in the legislation.
Categories Included in Regulation (EU) 2015/2283
Among the ten categories of Novel Foods are:
- Foods with a new or intentionally modified molecular structure.
- Foods consisting of, isolated from, or produced from microorganisms, fungi, or algae.
- Foods derived from mineral or plant sources.
- Ingredients obtained from animals or cell cultures.
- Foods produced using processes not previously applied before 1997.
- Artificial nanomaterials.
- Vitamins, minerals, and other substances with nutritional or physiological functions.
These categories cover a wide range of innovations, from new protein sources and ferments to functional ingredients and non-traditional raw materials.
Traditional Foods from Third Countries
A specific subcategory includes traditional foods from third countries — Novel Foods with a history of safe use for at least 25 years in the diet of a significant number of people in another part of the world.
Their authorization follows a simplified procedure, regulated by Commission Regulation (EU) 2017/2468, provided that they belong to one of the eligible categories and can demonstrate safety through documented evidence.
How to Determine Whether an Ingredient Is a Novel Food
Before applying for authorization, it is essential to determine whether an ingredient qualifies as a Novel Food. This involves three key steps:
- Consult the EU Novel Food Catalogue, a public database maintained by the European Commission.
- Review historical consumption evidence, demonstrating significant use before 1997.
- Submit a formal consultation to an EU Member State, as outlined in Regulation (EU) 2018/456, including manufacturing process details, use history, and product specifications.
This preliminary assessment typically takes 4 to 8 months, depending on the complexity of the ingredient and available documentation.
Pre-Market Safety Assessment (EFSA)
Every Novel Food is subject to a pre-market safety assessment conducted by the European Food Safety Authority (EFSA), which reviews toxicological, nutritional, and microbiological data before issuing its opinion.
The final authorization is granted by the European Commission, which adds the food to the EU Union List of Authorized Novel Foods (Commission Implementing Regulation (EU) 2017/2470).
Types of Authorizations and Proprietary Rights
- Generic authorizations: once approved, any market operator may commercialize the product.
- Specific authorizations: granted when a company develops a proprietary strain or ingredient, with exclusive rights valid for five years.
- Traditional foods: eligible for simplified authorization if they demonstrate long-term safe use outside the EU.
Transparency Regulation and Public Access
Since March 2021, the Transparency Regulation (EU) 2019/1381 has strengthened openness in the EU’s food risk assessment process.
It requires mandatory disclosure of all supporting studies, allows applicants to request pre-submission advice, and mandates the use of the Food Chain Electronic Platform for submissions.
Failure to comply may delay approval by up to six months.
Novel Food Authorization Procedure
The authorization process, detailed in Article 10 of Regulation (EU) 2015/2283 and Regulation (EU) 2017/2469, consists of the following steps:
- Submission of the application to the European Commission.
- Administrative and technical validation by EFSA.
- Scientific evaluation, typically lasting between 12 and 18 months.
- Final decision and inclusion in the EU Union List of Novel Foods.
In practice, the entire process may take between one and three and a half years, depending on the quality and completeness of the dossier.
Structure of the Application Dossier and Technical Requirements
The dossier is divided into three sections:
- Administrative part: identity of the Novel Food, applicant details, confidentiality requests, conditions of use, and regulatory status outside the EU.
- Public summary: non-confidential product description and safety evidence.
- Technical dossier: production process, compositional data, stability, toxicology, allergenicity, dietary exposure, and safety conclusions.
Specific Evaluations for Microorganisms, Nanomaterials, and Botanicals
EFSA applies specialized guidance depending on the type of Novel Food:
- Microorganisms: genomic sequencing (WGS), evaluation of antimicrobial resistance genes (QPS, AMR).
- Nanomaterials: risk assessment and nanoparticle detection.
- Botanicals: safety evaluation of plant extracts (Commission Regulation 2022/2340).
These scientific guidelines are periodically reviewed and published for public consultation.
Market Access and Labelling Requirements
Once authorized, the product is added to the EU Union List of Novel Foods (Regulation (EU) 2017/2470), updated approximately every two months. Each authorization specifies:
- Condiciones de uso (categoría y niveles máximos).
- Conditions of use (category and maximum levels).
- Labelling requirements.
This ensures uniform commercialization across Member States and provides legal certainty to food business operators entering the European market.
Recent Cases and EFSA Evaluation Criteria
In recent years, EFSA has issued both positive and negative opinions:
- Negative opinions: Wolffia globosa (high manganese exposure) and Cistanche tubulosa (adverse human effects).
- Positive opinions: Panax notoginseng and Astragalus membranaceus, approved at lower doses with broad safety margins.
A positive EFSA opinion does not automatically mean approval, as the European Commission must still issue the final decision based on risk management considerations.
How to Ensure a High-Quality Dossier and Avoid Delays
To maximize the chances of success in the approval of Novel Foods in the EU, applicants should:
- Follow all relevant EFSA guidance, including toxicity, allergenicity, and exposure assessment.
- Provide complete scientific evidence, even when results show uncertainties.
- Justify any deviation from official guidance.
- Maintain full transparency and traceability of data and studies.
- Review recent EFSA opinions on similar products to anticipate expectations.
A robust and well-documented submission significantly shortens evaluation timelines.
Key Recommendations
The EU’s Novel Food authorization system ensures food safety, innovation, and transparency across the internal market.
Although the process can be complex and time-consuming, compliance with EFSA’s scientific standards and a well-prepared dossier are the keys to success.
Ultimately, regulated and science-based food innovation represents a major opportunity for companies committed to sustainability and consumer trust.
